SURF Surface Oncology, Inc. Stock Quote

SURF [NASD]

Index	-	P/E	-	EPS (ttm)	-1.27	Insider Own	0.80%	Shs Outstand	48.61M	Perf Week	-15.87%
Market Cap	98.07M	Forward P/E	-	EPS next Y	-1.86	Insider Trans	-35.67%	Shs Float	36.65M	Perf Month	-15.05%
Income	-56.70M	PEG	-	EPS next Q	-0.46	Inst Own	63.50%	Short Float	7.24%	Perf Quarter	-47.45%
Sales	31.10M	P/S	3.15	EPS this Y	-214.00%	Inst Trans	25.88%	Short Ratio	3.49	Perf Half Y	-68.86%
Book/sh	3.02	P/B	0.58	EPS next Y	-44.00%	ROA	-28.30%	Target Price	11.40	Perf Year	-79.07%
Cash/sh	2.68	P/C	0.65	EPS next 5Y	-	ROE	-41.60%	52W Range	1.83 - 9.57	Perf YTD	-63.39%
Dividend	-	P/FCF	-	EPS past 5Y	-21.80%	ROI	-52.80%	52W High	-81.71%	Beta	1.65
Dividend %	-	Quick Ratio	9.40	Sales past 5Y	-16.50%	Gross Margin	-	52W Low	-4.37%	ATR	0.19
Employees	67	Current Ratio	9.40	Sales Q/Q	-99.80%	Oper. Margin	-	RSI (14)	34.85	Volatility	8.09% 9.98%
Optionable	Yes	Debt/Eq	0.17	EPS Q/Q	133.90%	Profit Margin	-	Rel Volume	0.87	Prev Close	1.87
Shortable	Yes	LT Debt/Eq	0.17	Earnings	May 09 BMO	Payout	-	Avg Volume	760.86K	Price	1.75
Recom	1.50	SMA20	-16.27%	SMA50	-28.86%	SMA200	-63.39%	Volume	658,692	Change	-6.42%

May-18-21

Initiated

BTIG Research

Buy

$17

Sep-04-20

Initiated

H.C. Wainwright

Buy

$11

Aug-28-20

Initiated

Wedbush

Outperform

$12

Sep-19-18

Initiated

Robert W. Baird

Outperform

May-14-18

Initiated

Goldman

Neutral

$17

May-14-18

Initiated

Evercore ISI

Outperform

$26

May-17-22 04:30PM	Surface Oncology to Participate in Upcoming Investor Conferences GlobeNewswire +10.64%
May-11-22 06:28AM	Bullish: Analysts Just Made A Substantial Upgrade To Their Surface Oncology, Inc. (NASDAQ:SURF) Forecasts Simply Wall St. -11.31%
May-09-22 07:10AM	Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2022 GlobeNewswire
May-06-22 04:30PM	Surface Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -8.73%
08:50AM	Health Check: How Prudently Does Surface Oncology (NASDAQ:SURF) Use Debt? Simply Wall St.
Apr-27-22 04:15PM	Surface Oncology to Present Clinical Update on SRF388 at American Society of Clinical Oncology Annual Meeting GlobeNewswire
Apr-21-22 04:05PM	Surface Oncology Named one of the 2022 Best Places to Work by Boston Business Journal GlobeNewswire -8.85%
Apr-14-22 07:30AM	Surface Oncology Announces Initiation of Phase 2 Studies Evaluating SRF388 in Patients with Hepatocellular Carcinoma and Non-Small-Cell Lung Cancer GlobeNewswire
Apr-11-22 09:47AM	Surface Oncology Highlights New SRF388 Data At AACR Meeting Benzinga
Apr-08-22 04:01PM	Surface Oncology Presents New SRF388 Data at the American Association for Cancer Research (AACR) Annual Meeting 2022 GlobeNewswire -5.46%
Apr-01-22 04:43PM	Surface Oncology Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Mar-31-22 07:30AM	Surface Oncology Achieves $30 Million Milestone with First Patient Dosed in GlaxoSmithKline Phase 1 Study GlobeNewswire
Mar-15-22 07:30AM	Surface Oncology Appoints Theresa Boni as General Counsel GlobeNewswire
Mar-02-22 08:42AM	Why Surface Oncology (SURF) Might Surprise This Earnings Season Zacks -7.14%
07:10AM	Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021 GlobeNewswire
Mar-01-22 03:00PM	Surface Oncology, Inc. (SURF) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release Zacks
08:55AM	Perrigo (PRGO) Beats Q4 Earnings and Revenue Estimates Zacks
Feb-28-22 04:30PM	Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowens 42nd Annual Health Care Conference GlobeNewswire
Feb-24-22 07:55AM	Do Institutions Own Surface Oncology, Inc. (NASDAQ:SURF) Shares? Simply Wall St. +7.81%
Feb-22-22 08:05AM	Medtronic (MDT) Q3 Earnings Top Estimates Zacks
Feb-10-22 07:00AM	Surface Oncology to Participate in Citi's 2022 Virtual Immuno-Oncology Summit GlobeNewswire
Jan-10-22 01:49PM	Shareholders in Surface Oncology (NASDAQ:SURF) are in the red if they invested a year ago Simply Wall St.
Dec-15-21 07:05AM	Surface Oncology Appoints Denice Torres as Chair of the Board of Directors GlobeNewswire
Dec-06-21 09:30AM	Surface Oncology Presents Promising Clinical Data on SRF617 at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021 GlobeNewswire
Dec-03-21 07:00AM	Surface Oncology Named a 2021 Top Place to Work by the Boston Globe GlobeNewswire -6.93%
Dec-02-21 07:00AM	Surface Oncology to Present New Clinical Data from Ongoing SRF617 Phase 1 Trial at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021 GlobeNewswire
Dec-01-21 07:00AM	Surface Oncology Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG GlobeNewswire
Nov-29-21 06:44AM	Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought Motley Fool
Nov-26-21 06:57AM	Should Weakness in Surface Oncology, Inc.'s (NASDAQ:SURF) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
Nov-09-21 08:10AM	Preclinical Data Supporting Therapeutic Potential of Surface Oncologys Lead Clinical Programs, SRF617 and SRF388, Presented at the Society for Immunotherapy of Cancer 2021 Annual Meeting GlobeNewswire -6.88%
Nov-08-21 03:44PM	10 Best Stocks Under $11 in Cathie Woods Portfolio Insider Monkey
07:00AM	Surface Oncology to Participate in the 2021 Annual Cowen IO Next Summit GlobeNewswire
Nov-04-21 07:10AM	Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2021 GlobeNewswire
Nov-02-21 07:00AM	Surface Oncology to Present Preclinical Data for Lead Clinical Programs at the Society for Immunotherapy of Cancer 2021 Annual Meeting GlobeNewswire
Oct-12-21 11:21AM	Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt? Simply Wall St.
Oct-04-21 10:56AM	Hedge Funds Arent Crazy About Surface Oncology, Inc. (SURF) Anymore Insider Monkey
07:00AM	Surface Oncology Announces New Randomized Phase 2 Clinical Study Evaluating SRF388 in Patients with First-Line Hepatocellular Carcinoma in Clinical Collaboration with Roche GlobeNewswire
Sep-20-21 05:44PM	Why AstraZeneca and Surface Oncology Rose Today Motley Fool
Sep-13-21 09:02AM	New Strong Sell Stocks for September 13th Zacks
Aug-23-21 12:03PM	What Is The Ownership Structure Like For Surface Oncology, Inc. (NASDAQ:SURF)? Simply Wall St. +11.21%
Aug-05-21 07:10AM	Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2021 GlobeNewswire +8.72%
Jul-08-21 07:00AM	Surface Oncology's (NASDAQ:SURF) Shareholders Are Down 58% On Their Shares Simply Wall St.
07:00AM	Surface Oncology Appoints Denice Torres to Board of Directors GlobeNewswire
Jun-04-21 10:17AM	Surface Oncology's SRF388 Shows Promising Anticancer Activity in Pretreated Patients Benzinga -9.82%
10:04AM	Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer Benzinga
07:05AM	SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting GlobeNewswire
07:00AM	Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular Carcinoma GlobeNewswire
May-28-21 06:20AM	This Is Why Surface Oncology Is a Great Stock to Buy Right Now Motley Fool
May-24-21 08:53AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Surface Oncology, Inc.'s NASDAQ:SURF) Stock? Simply Wall St.
May-18-21 08:48AM	Implied Volatility Surging for Surface Oncology (SURF) Stock Options Zacks +5.91%
May-16-21 06:20AM	Could Surface Oncology Be a Millionaire-Maker Stock? Motley Fool
May-05-21 06:45AM	Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2021 GlobeNewswire
Apr-28-21 04:05PM	Surface Oncology to Present Clinical Updates for SRF388 and SRF617 GlobeNewswire
Apr-27-21 07:00AM	Surface Oncology Expands Leadership Team with Key Executive Appointment and Promotions GlobeNewswire
Apr-19-21 07:00AM	Surface Oncology Named a 2021 Best Places to Work Company by Boston Business Journal GlobeNewswire
Apr-09-21 07:53AM	Surface Oncology Presents Promising Preclinical Data for Lead Immunotherapy Product Candidates at the American Association for Cancer Research Annual Meeting GlobeNewswire
Apr-08-21 07:32AM	These 4 Measures Indicate That Surface Oncology (NASDAQ:SURF) Is Using Debt Safely Simply Wall St.
Mar-31-21 11:12AM	Why Surface Oncology Stock Is Soaring Today Motley Fool +7.59%
Mar-30-21 06:11PM	Why Surface Oncology Is Flying Higher After Hours Today Motley Fool -8.92%
04:30PM	Surface Oncologys SRF617 Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer GlobeNewswire
Mar-23-21 11:47PM	TSMC, BYD, Komatsu, Surface Oncology And 3D Systems What Cathie Wood's Ark Bought And Sold Today Benzinga -8.90%
Mar-18-21 08:00AM	Shark Bites: This Oncology Biotech Has 3 Positives Going for It TheStreet.com
Mar-17-21 08:01AM	Surface Oncology Rises on Rumor ARK's Cathie Wood Will Talk About It At Event Investing.com
Mar-10-21 04:35PM	Surface Oncology to Present Preclinical Data for Lead Product Programs at the American Association for Cancer Research Annual Meeting GlobeNewswire
Mar-09-21 08:25AM	Surface Oncology, Inc. (SURF) Q4 Earnings and Revenues Beat Estimates Zacks +12.36%
07:01AM	Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2020 GlobeNewswire
07:00AM	Surface Oncology to Collaborate with Merck on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors GlobeNewswire
06:43AM	Surface Oncology (SURF) is Oversold: Can It Recover? Zacks
Mar-05-21 08:48AM	Should You Buy Surface Oncology (SURF) Ahead of Earnings? Zacks
Mar-02-21 12:30PM	Surface Oncology, Inc. (SURF) to Report Q4 Results: Wall Street Expects Earnings Growth Zacks
Feb-24-21 07:00AM	Surface Oncology to Participate in Upcoming March Investor Conferences GlobeNewswire
Feb-23-21 07:25AM	The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga
Feb-22-21 06:21AM	What Type Of Shareholders Make Up Surface Oncology, Inc.'s (NASDAQ:SURF) Share Registry? Simply Wall St.
Feb-11-21 07:00AM	Surface Oncology to Appoint Robert Ross, M.D., as President and Chief Executive Officer GlobeNewswire
Jan-19-21 03:25PM	Surface Oncology Is Set for Further Gains - How to Buy It TheStreet.com +9.11%
Jan-13-21 08:39AM	Are Options Traders Betting on a Big Move in Surface Oncology (SURF) Stock? Zacks
Jan-11-21 06:00AM	Surface Oncology to Participate in H.C. Wainwright Bioconnect 2021 Conference GlobeNewswire +5.23%
Dec-22-20 12:20PM	Earnings Estimates Moving Higher for Surface Oncology, Inc. (SURF): Time to Buy? Zacks +7.77%
04:37AM	If You Had Bought Surface Oncology (NASDAQ:SURF) Stock A Year Ago, You Could Pocket A 498% Gain Today Simply Wall St.
Dec-17-20 03:35PM	Why Surface Oncology Stock Sank Today Motley Fool -14.56%
08:10AM	The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga
06:55AM	Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program GlobeNewswire
Dec-14-20 07:07AM	Where Do Hedge Funds Stand On Surface Oncology, Inc. (SURF)? Insider Monkey +10.67%
Dec-07-20 08:29AM	These Were the 5 Best Cancer Stocks Of 2020 Motley Fool
Nov-25-20 07:00AM	Surface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx Conference GlobeNewswire
Nov-15-20 08:39AM	2 Biotech Stocks That Could Have Tripled Your Money This Year Motley Fool
06:57AM	3 Top Biotech Stocks to Watch in November Motley Fool
Nov-13-20 07:05AM	Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials GlobeNewswire -7.22%
Nov-11-20 07:00AM	Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer GlobeNewswire
Nov-10-20 06:20AM	Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2020 GlobeNewswire
Nov-09-20 04:25PM	Surface Oncology to Present at the Cowen IO Next Summit GlobeNewswire
09:00AM	Surface Oncology to Present SRF388 and SRF114 Preclinical Data at the Upcoming Society for Immunotherapy for Cancer 2020 Virtual Conference GlobeNewswire
Nov-05-20 09:43AM	Zacks.com featured highlights include: Matson, Surface Oncology, Green Brick Partners, Merchants Bancorp and Herc Holdings Zacks +6.03%
Oct-26-20 04:05PM	Surface Oncology to Report SRF388 Preclinical Data at the Upcoming International Cytokine and Interferon Societys Cytokines 2020 Virtual Conference GlobeNewswire -8.57%
Oct-20-20 01:03PM	Is Surface Oncology (NASDAQ:SURF) Using Too Much Debt? Simply Wall St. +10.94%
Oct-19-20 12:32PM	Zacks.com featured highlights include: Daqo, Surface Oncology, Covenant, Herc and Castle Biosciences Zacks -10.72%
Oct-12-20 03:41PM	Why Surface Oncology Stock Soared Today Motley Fool +32.07%
Sep-16-20 05:05PM	Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire
Sep-15-20 07:23AM	Surface Oncology's Shares March Higher, Can It Continue? Zacks
Sep-11-20 03:00PM	Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference GlobeNewswire

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FEES JESSICA	Chief Financial Officer	Jul 21	Sale	6.10	19,854	121,109	79,329	Jan 14 08:30 PM
ONEILL ALISON	Chief Medical Officer	Jul 21	Sale	6.10	14,809	90,335	30,191	Jan 14 08:30 PM
Nogelo Liisa I	Chief Legal Officer	Jul 21	Sale	6.10	26,325	160,582	53,675	Jan 14 08:30 PM
ROSS ROBERT W.	Chief Executive Officer	Jul 21	Sale	6.10	33,500	204,350	54,500	Jan 14 08:30 PM
Palombella Vito J.	Chief Scientific Officer	Jul 21	Sale	6.10	26,325	160,582	53,675	Jan 14 08:30 PM
Goater Jeff	Director	Jul 21	Sale	6.10	127,778	779,446	129,222	Jan 14 08:30 PM
Goater Jeff	Director	Jun 11	Option Exercise	4.14	10,273	42,530	272,273	Jun 11 08:30 PM
Goater Jeff	Director	Jun 11	Sale	7.61	15,273	116,226	257,000	Jun 11 08:30 PM
Goater Jeff	Director	Jun 10	Option Exercise	4.14	234,727	971,770	496,727	Jun 11 08:30 PM
Goater Jeff	Director	Jun 10	Sale	7.66	234,727	1,798,619	262,000	Jun 11 08:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience